Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and Opportunities for Pancreatic Cancer Immunotherapy
Adham S. Bear, Robert H. Vonderheide, Mark H. O’Hara
Cancer Cell (2020) Vol. 38, Iss. 6, pp. 788-802
Open Access | Times Cited: 443

Showing 26-50 of 443 citing articles:

NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1
Xiaozhen Zhang, Xing Huang, Jian Xu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 87
Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine
Xing Huang, Gang Zhang, Tianyu Tang, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 67
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
Pat Gulhati, Aislyn Schalck, Shan Jiang, et al.
Nature Cancer (2022)
Open Access | Times Cited: 64
RETRACTION: Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
Xiaofei Zhu, Yangsen Cao, Wenyu Liu, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 8, pp. 1093-1102
Closed Access | Times Cited: 60
Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy
Lingyue Liu, Xing Huang, Fukang Shi, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 59
Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer
Libo Wang, Zaoqu Liu, Ruopeng Liang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 59
Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21
Xuan Lin, Long‐Yun Ye, Xu Wang, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3678-3678
Open Access | Times Cited: 58
3D tumor spheroid microarray for high-throughput, high-content natural killer cell-mediated cytotoxicity
Sneha Gopal, Seok‐Joon Kwon, Bosung Ku, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 58
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, et al.
Cellular Oncology (2022) Vol. 46, Iss. 1, pp. 17-48
Closed Access | Times Cited: 58
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
Xiaofei Zhu, Yangsen Cao, Wenyu Liu, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 3, pp. e105-e115
Closed Access | Times Cited: 56
HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer
Yingke Zhou, Xin Jin, Haixin Yu, et al.
Theranostics (2022) Vol. 12, Iss. 5, pp. 2080-2094
Open Access | Times Cited: 43
Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity
Bhalchandra Mirlekar, Yan Wang, Sirui Li, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 9, pp. 100744-100744
Open Access | Times Cited: 41
Biomaterial-based platforms for tumour tissue engineering
Rodrigo Curvello, Verena Kast, Paloma Ordóñez‐Morán, et al.
Nature Reviews Materials (2023) Vol. 8, Iss. 5, pp. 314-330
Open Access | Times Cited: 39
Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy
Yanlong Shi, Yizhu Wang, Hui Dong, et al.
APOPTOSIS (2023) Vol. 28, Iss. 9-10, pp. 1423-1435
Open Access | Times Cited: 39
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Nanoparticle-mediated TRPV1 channel blockade amplifies cancer thermo-immunotherapy via heat shock factor 1 modulation
Ting Li, Shuhui Jiang, Ying Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 38
Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers
Huan Zhang, Kailei Cao, Jingrong Xiang, et al.
Cancer Letters (2023) Vol. 571, pp. 216345-216345
Closed Access | Times Cited: 38
Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy
Xiaoyu Liu, Yaping Zhuang, Wei Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis
Xing Liu, Xinhui Peng, Shuai Cen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 33
Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
Ying Li, Shuai Xiang, Wenjun Pan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 31
Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 31
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zining Zhang, Heng Zhang, Xiang Liao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 30
Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics
Xin Li, Yue Gao, Helin Li, et al.
Progress in Materials Science (2023) Vol. 140, pp. 101170-101170
Closed Access | Times Cited: 29
Immune profiling and prognostic model of pancreatic cancer using quantitative pathology and single-cell RNA sequencing
Kai Chen, Qi Wang, Xinxin Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 27
A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
Zhuolong Zhou, Kevin Van der Jeught, Yujing Li, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 26

Scroll to top